MEDICLINIC INTERNATIONAL LIMITED - Secondary Listing of Mediclinic on the Namibian Stock Exchange

Secondary Listing of Mediclinic on the Namibian Stock Exchange

MEDICLINIC INTERNATIONAL LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
JSE share code: MDC NSX share code: MCI
(“Mediclinic” or “the Company”)



                            SECONDARY LISTING OF MEDICLINIC
                            ON THE NAMIBIAN STOCK EXCHANGE
APPROVAL OF SECONDARY LISTING
Shareholders are advised that the Namibian Stock Exchange (“NSX”) approved the secondary listing of Mediclinic on the NSX with
effect from Tuesday, 2 December 2014 under share code “MCI”. The Company’s primary listing remains on the JSE.

RATIONALE FOR SECONDARY NSX LISTING
Mediclinic believes that the NSX listing will enhance the ability of Namibian investors to invest in Mediclinic shares thereby
broadening the Company’s shareholder base; and also assist in building relationships with its Namibian stakeholders.

ABOUT MEDICLINIC
Mediclinic is an international private healthcare group with operations in South Africa, Namibia, Switzerland and the United Arab
Emirates. The Mediclinic group is focused on providing acute care, specialist-orientated, multi-disciplinary hospital services and
related service offerings.

Mediclinic’s Namibian operations currently consist of three private hospitals in Windhoek, Swakopmund and Otjiwarongo.

Stellenbosch
1 December 2014

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com

             JSE sponsor: RAND MERCHANT BANK                                             NSX sponsor:
              (A division of FirstRand Bank Limited)                            Simonis Storm Securities (Pty) Ltd

Date: 01/12/2014 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.